Publication | Closed Access

Drug repurposing screening identifies bortezomib and panobinostat as drugs targeting cancer associated fibroblasts (CAFs) by synergistic induction of apoptosis

Synergistic InductionOncologyMedicineCell DeathPathologyIdentifies BortezomibAnti-cancer AgentCancer TreatmentPharmacologyTumor MicroenvironmentCancer Research